OncoIndx genomic profiling
A 1,080-gene panel covering SNVs, indels, fusions, CNVs and genome-wide LOH, plus TMB, MSI and HRD signatures.
JV scientific partner · 1Cell.Ai
The scientific team behind PranAmritam
Our joint-venture scientific partner works where deep cell science meets data science. They build single-cell multi-omics biomarkers and cell-based liquid biopsy, with accredited laboratories in the United States and India.
- PhD scientists
- 30+
- Patients impacted
- 35,000+
- CTC positivity, stage II–IV (n = 2,062)
- 83%
- PPV, CTC liquid biopsy assay
- 99.5%
Leadership
Seasoned leaders with deep domain expertise
Together, the leadership team brings around 400 years of combined experience in oncology, diagnostics, software and operations.
Mohan Uttarwar
Co-founder & Chief Executive Officer
Dr. Gowhar Shafi
Co-founder & Chief Medical Informatics Officer
Dr. Ken Bloom
Chief Medical Officer
Dr. Ajay Pandita
Chief Scientific Officer
Srikanth Nandiraju
Chief Technology Officer
Dr. Nilesh Shah
India Managing Director
Scientific & clinical team
Research, clinical and laboratory leads
Dr. Atul Bharde
VP – R&D
Dr. Ganesh Divekar
Head – Clinical Research
Dr. Gunjan Agrawal
Head – Medical Affairs
Dr. Aarthi Ramesh
Principal Scientist – Single-Cell Bioinformatics
Dr. Sandhya Iyer
Principal Scientist – Products & Scientific Affairs
Dr. P Shivamurthy
Data Scientist – Imaging AI
Dr. Hrishitha Kothavade
Lab Director, Pune
Dr. Tejas Shah
Head of Lab Operations, Pune
Dr. Sankar Mohan
Head of Lab Operations, Foster City
- Software & AI
- 50+
- R&D
- 40+
- Lab operations
- 50+
- Commercial
- 40+
Platform
Capabilities the partner brings to the JV
OncoIncytes cell biopsy
Multi-marker capture of viable circulating tumour cells, ready for downstream DNA, RNA and protein analysis from the same cell.
Single-cell protein targets
Multiplexed immunofluorescence across 20–30 targets, including HER2, PD-L1, Trop-2 and Claudin 18.2, on single CTCs.
iCore data platform
An intelligent clinical omics engine that links wet-lab operations and dry-lab analytics with agentic AI.
Why this partnership
Precision diagnostics to support non-mRNA cancer vaccines
- Patient-level tumour biomarkers to guide antigen selection for non-mRNA vaccine candidates
- Serial liquid-biopsy monitoring of immune response and resistance during clinical studies
- Accredited laboratory infrastructure for translational and trial support in India
- Bioinformatics and AI pipelines to stratify patients and read out trial results
Credentials
Accredited, validated, global
Clinical study collaborators
- MD Anderson Cancer Center
- Memorial Sloan Kettering
- Stanford
- Medical College of Wisconsin
- Ohio State University
- VA / Stanford
Accreditations
- CLIA certified (US)
- CAP accredited
- NABL accredited (MC-7348)
- DCGI-approved OncoDiscover
- ISO 13485 underway
- CE-IVDR in process
Locations
Foster City, California
Headquarters · CLIA/CAP laboratory
Pune, India
Clinical laboratory · NABL/CAP
Mumbai, India
Corporate office
Figures come from 1Cell.Ai materials and cover the partner's diagnostic platform. They are not results of PranAmritam vaccine candidates. Clinical collaborations listed are studies run by 1Cell.Ai.
Raising up to US$100M
Help build affordable cancer immunotherapy in India
Qualified investors can request the investor deck, financial model and data-room access.